LSBCF
Price
$0.73
Change
-$0.07 (-8.75%)
Updated
Sep 25 closing price
Capitalization
30.09M
STTK
Price
$2.26
Change
-$0.03 (-1.31%)
Updated
Sep 26, 02:24 PM (EDT)
Capitalization
109.7M
46 days until earnings call
Interact to see
Advertisement

LSBCF vs STTK

Header iconLSBCF vs STTK Comparison
Open Charts LSBCF vs STTKBanner chart's image
LakeShore Biopharma
Price$0.73
Change-$0.07 (-8.75%)
Volume$12.05K
Capitalization30.09M
Shattuck Labs
Price$2.26
Change-$0.03 (-1.31%)
Volume$500
Capitalization109.7M
LSBCF vs STTK Comparison Chart in %
Loading...
LSBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSBCF vs. STTK commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSBCF is a Hold and STTK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (LSBCF: $0.73 vs. STTK: $2.29)
Brand notoriety: LSBCF and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSBCF: 14% vs. STTK: 4%
Market capitalization -- LSBCF: $30.09M vs. STTK: $109.7M
LSBCF [@Biotechnology] is valued at $30.09M. STTK’s [@Biotechnology] market capitalization is $109.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSBCF’s FA Score shows that 1 FA rating(s) are green whileSTTK’s FA Score has 1 green FA rating(s).

  • LSBCF’s FA Score: 1 green, 4 red.
  • STTK’s FA Score: 1 green, 4 red.
According to our system of comparison, STTK is a better buy in the long-term than LSBCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSBCF’s TA Score shows that 5 TA indicator(s) are bullish while STTK’s TA Score has 5 bullish TA indicator(s).

  • LSBCF’s TA Score: 5 bullish, 3 bearish.
  • STTK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LSBCF is a better buy in the short-term than STTK.

Price Growth

LSBCF (@Biotechnology) experienced а -7.64% price change this week, while STTK (@Biotechnology) price change was +2.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

STTK is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STTK($110M) has a higher market cap than LSBCF($30.1M). STTK YTD gains are higher at: 89.256 vs. LSBCF (-78.899).
LSBCFSTTKLSBCF / STTK
Capitalization30.1M110M27%
EBITDAN/A-61.22M-
Gain YTD-78.89989.256-88%
P/E RatioN/AN/A-
RevenueN/A3M-
Total CashN/A50.5M-
Total DebtN/A2.97M-
TECHNICAL ANALYSIS
Technical Analysis
LSBCFSTTK
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
55%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
41%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
LSBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKIMF15.45N/A
N/A
Bankinter, S.A.
RVTI0.02N/A
N/A
Rival Technologies, Inc.
FGHQF0.15N/A
N/A
Frontage Hldgs Corp.
HROGF6.82N/A
N/A
Hirogin Holdings Inc.
LQWDF1.14-0.04
-3.39%
LQWD TECHNOLOGIES CORP.

LSBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LSBCF has been loosely correlated with STTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LSBCF jumps, then STTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSBCF
1D Price
Change %
LSBCF100%
-8.74%
STTK - LSBCF
38%
Loosely correlated
-2.55%
BCTX - LSBCF
30%
Poorly correlated
+3.38%
GLTO - LSBCF
27%
Poorly correlated
+4.46%
PROK - LSBCF
26%
Poorly correlated
-3.68%
GNFT - LSBCF
23%
Poorly correlated
-2.64%
More